Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor detection, technology services, equipment/reagents, laboratory overall solution, and big data services. It also offers scientific research services and medical testing services and products. In addition, the company provides GENOSi, an intelligent agent cloud platform; and NovaSeq, a next-generation sequencing platform. It serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macau, and Taiwan. The company was founded in 1997 and is headquartered in Beijing, China.